Introduction
Methods
Study Setting
Ethical Considerations
Study Population
Statistical Analysis
Results
Total number of employees in the register | 2002 | 2005 | 2008 |
---|---|---|---|
N = 1,011,555 | N = 1,010,686 | N = 1,012,345 | |
Breast cancer | |||
Women | 401 | 516 | 514 |
Men | – | – | – |
Genital cancer | |||
Women | 191 | 305 | 234 |
Men | 95 | 130 | 164 |
Gastrointestinal cancer | |||
Women | 62 | 71 | 85 |
Men | 162 | 162 | 212 |
Lung cancer | |||
Women | 44 | 56 | 67 |
Men | 88 | 89 | 99 |
Skin cancer | |||
Women | 28 | 42 | 31 |
Men | 51 | 55 | 66 |
Blood malignancies | |||
Women | 29 | 32 | 26 |
Men | 58 | 64 | 58 |
All cancers | |||
<40 years | 260 (22%) | 344 (23%) | 274 (18%) |
40–49 years | 393 (33%) | 447 (29%) | 420 (27%) |
≥50 years | 549 (45%) | 728 (48%) | 856 (55%) |
Missing | 2 | 3 | 6 |
Total cancer cases | 1209 (100%) | 1522 (100%) | 1556 (100%) |
Referencea
| |||
<40 years | 82 (10%) | 112 (11%) | 89 (9%) |
40–49 years | 302 (36%) | 320 (32%) | 311 (32%) |
≥50 years | 457 (54%) | 562 (57%) | 576 (59%) |
Missing | – | 1 | 1 |
Total reference group | 841 (100%) | 995 (100%) | 977 (100%) |
Percentage of Employees with RTW
2002 | 2005 | 2008 | χ2
p-value | |||||
---|---|---|---|---|---|---|---|---|
Partiala (%) | Fullb (%) | Partiala (%) | Fullb (%) | Partiala (%) | Fullb (%) | Partiala (%) | Fullb (%) | |
Breast cancer | 88 | 85 | 82 | 75 | 71 | 59 | <0.01 | <0.01 |
Genital cancer | 94 | 91 | 91 | 88 | 85 | 79 | 0.01 | <0.01 |
Gastrointestinal cancer | 78 | 72 | 69 | 63 | 53 | 44 | <0.01 | <0.01 |
Lung cancer | 65 | 61 | 52 | 47 | 41 | 33 | <0.01 | <0.01 |
Skin cancer | 87 | 80 | 92 | 88 | 92 | 86 | 0.53 | 0.34 |
Blood malignancies | 83 | 76 | 72 | 68 | 68 | 54 | 0.07 | <0.01 |
All cancers | ||||||||
Total | 85 | 80 | 80 | 74 | 69 | 60 | <0.01 | <0.01 |
<40 years | 91 | 87 | 81 | 77 | 76 | 69 | <0.01 | <0.01 |
40-49 years | 86 | 81 | 83 | 77 | 72 | 60 | <0.01 | <0.01 |
≥50 years | 81 | 77 | 77 | 71 | 65 | 57 | <0.01 | <0.01 |
Referencec
| ||||||||
Total | 89 | 87 | 87 | 83 | 81 | 75 | <0.01 | <0.01 |
<40 years | 89 | 87 | 85 | 78 | 78 | 78 | 0.12 | 0.23 |
40-49 years | 91 | 89 | 90 | 86 | 80 | 76 | <0.01 | <0.01 |
≥50 years | 89 | 86 | 86 | 82 | 82 | 74 | <0.01 | <0.01 |
Time to Partial and Full RTW
Partial RTWa
| Full RTWb
| |||||
---|---|---|---|---|---|---|
2002 | 2005 | 2008 | 2002 | 2005 | 2008 | |
Breast cancer | 1.00 | 0.91 (0.76–1.10) | 0.87 (0.72–1.06) | 1.00 | 0.82 (0.67–0.99)** | 0.70 (0.57–0.86)** |
Genital cancer | 1.00 | 1.07 (0.87–1.32) | 1.06 (0.86–1.31) | 1.00 | 1.03 (0.84–1.28) | 1.01 (0.85–1.25) |
Gastrointestinal cancer | 1.00 | 0.82 (0.62–1.09) | 0.66 (0.50–0.88)** | 1.00 | 0.79 (0.59–1.07) | 0.57 (0.42–0.77)** |
Lung cancer | 1.00 | 0.75 (0.50–1.13) | 0.56 (0.37–0.85)** | 1.00 | 0.67 (0.44–1.04) | 0.46 (0.29–0.72)** |
Skin cancer | 1.00 | 1.25 (0.83–1.89) | 1.29 (0.85–1.96) | 1.00 | 1.37 (0.89–2.11) | 1.25 (0.81–1.93) |
Blood malignancies | 1.00 | 0.73 (0.47–1.14) | 0.75 (0.47–1.18) | 1.00 | 0.79 (0.50–1.26) | 0.64 (0.39–1.05) |
Total | 1.00 | 0.95 (0.85–1.06) | 087 (0.78–0.98)** | 1.00 | 0.91 (0.81–1.02) | 0.76 (0.68–0.86)** |